Autophagy is a conserved catabolic process that delivers the cytosol and cytosolic constituents to the lysosome. Its fundamental role is to maintain cellular homeostasis and to protect cells from varying insults, including misfolded proteins and damaged organelles. Beyond these roles, the highly specialized cells of the brain have further adapted autophagic pathways to suit their distinct needs. In this review, we briefly summarize our current understanding of the different forms of autophagy and then offer a closer look at how these pathways impact neuronal and glial functions. The emerging evidence indicates that not only are autophagy pathways essential for neural health, but they have a direct impact on developmental and neurodegenerative processes. Taken together, as we unravel the complex roles autophagy pathways play, we will gain the necessary insight to modify these pathways to protect the human brain and treat neurodegenerative diseases. 
INTRODUCTION
The highly specialized cells of the vertebrate brain depend on catabolic processes not only to eliminate waste, but also to protect against variations in nutrient availability, to promote cellular remodeling, and to defend against invading pathogens. Degradation is achieved primarily by two pathways, the ubiquitin-proteasome system (UPS) and the autophagy-lysosome system. Whereas the proteasome is responsible for most protein turnover (Ciechanover et al. 2000) , the lysosome is responsible for recycling not only proteins but also lipids, nucleic acids, and polysaccharides. Identified by de Duve in the 1950s, the lysosome is a membrane-bound organelle that contains a diverse array of hydrolytic enzymes that drive catabolysis under an acidic pH. The delivery of substrates into the lysosomal lumen is achieved by two trafficking pathways: Endocytosis transports extracellular, transmembrane, and membrane-bound constituents; and autophagy transports cytosolic substrates using three distinct pathways, i.e., microautophagy, CMA (chaperone-mediated autophagy), and macroautophagy.
Lysosome-mediated degradation is essential for neural health, and the appreciation of autophagic pathways in the healthy and diseased brain continues to grow. Emerging evidence indicates that the highly specialized neurons and glia not only maintain the basal function of autophagy that is shared across all cells, but also have adapted these processes to suit their specific needs. In this review, we provide a brief overview of our current understanding of the three forms of autophagy and discuss how these pathways impact neurons and glia of the developing and adult brain.
lumen. Although there is still much to be learned regarding the mechanistic understanding of these pathways, growing evidence indicates that direct substrate delivery to the lysosome, especially via CMA, can have a profound impact on neural function.
Microautophagy
In microautophagy, substrates and the surrounding cytosol are engulfed by the lysosomal membrane. It is the least understood autophagic pathway, although its original description arises from the pioneering ultrastructural studies of starved hepatocytes (reviewed in Mijaljica et al. 2011) . There is currently little mechanistic understanding of microautophagy, which gives rise to the suggestion that it occurs only in yeast. Recently, however, a microautophagy-like process was reported to occur in mammalian cells during the formation of multivesicular bodies (MVBs) . Substrates are recognized and targeted to late endosomes in an hsc70 (heat shock cognate 70)-dependent manner, a component also required for CMA.
Chaperone-Mediated Autophagy
CMA relies on the directed import of individual proteins into the lysosomal lumen by a concerted effort of chaperone proteins and the single spanning lysosomal membrane protein LAMP2A (lysosome-associated membrane protein 2A) (Figure 1 ) (Kaushik & Cuervo 2012) . Proteins targeted for CMA are recognized by a pentapeptide motif similar to KFERQ, which permits its interaction with the cytosolic chaperone, hsc70. Hsc70 traffics the cargo to the lysosome surface, and the subsequent interaction with LAMP2A imports the substrate into the lumen with the help of a lysosome-associated hsc70. CMA has been studied exclusively in mammals, and the lack of conservation in earlier organisms has slowed our mechanistic understanding of this pathway (Bejarano & Cuervo 2010) .
First identified as a selective form of lysosomal uptake in the early 1980s (Backer et al. 1983 ), CMA was shown by Dice and colleagues (1990) to be a selective protein degradative process in response to serum withdrawal. In further studies using paradigms of prolonged starvation, Dice, Knecht, and others found that whereas the degradation of most proteins diminished over time, proteolysis of CMA substrates increased (Cuervo et al. 1995) . This finding led to the hypothesis that during periods of starvation, the initial, bulk catabolism is driven by macroautophagy, which is then followed by the more selective degradation of CMA. Consistent with this hypothesis, cross talk between macroautophagy and CMA has been reported, but the underlying mechanism remains unclear . Several disease-related proteins including α-synuclein (Cuervo et al. 2004 ) have recently been identified as CMA substrates, suggesting that CMA may also play a housekeeping role in neurons (Vogiatzi et al. 2008) .
Although deletion of the LAMP2A isoform has not been reported, a primary defect affecting all LAMP2 isoforms leads to Danon disease, a rare X-linked dominant disorder characterized by myopathy and cardiomyopathy (Danon et al. 1981 , Nishino et al. 2000 . Typically, male patients also present with mild intellectual disability, and although no structural brain abnormalities have been reported (Sugie et al. 2002 ), brain development still may be affected. Whether a loss of LAMP2 affects the adult brain remains unknown (Eskelinen et al. 2003 , Tanaka et al. 2000 .
MACROAUTOPHAGY
Macroautophagy first requires the synthesis of a multilamellar vesicle called the autophagosome (AP), which fuses into the endolysosomal system to deliver its cargo (Figure 1) . In the brain, macroautophagy influences developmental processes as well as degeneration and death; despite The three forms of autophagy. An illustrated summary of the three forms of autophagy-microautophagy, chaperone-mediated autophagy, and macroautophagy-and their respective interactions with the lysosome. this importance, however, many fundamental questions about neural macroautophagy still remain unanswered. It may therefore be surprising that neurons were one of the first cell types used in the identification and ultrastructural characterization of this pathway (Dixon 1967 , Holtzman & Novikoff 1965 . Nonetheless, the key biochemical contributions that followed focused on the liver (reviewed in Yang & Klionsky 2010) , driving most of our physiological understanding of macroautophagy today.
In the mid-1990s, Ohsumi and colleagues uncovered that macroautophagy is conserved in yeast, propelling our mechanistic insight into this pathway (Baba et al. 1994 , Takeshige et al. 1992 . The molecular machinery is currently composed of more than 30 autophagy-related (ATG) genes in yeast, 18 of which have mammalian homologs. Although we briefly describe the molecular underpinnings of macroautophagy here, further details can be found elsewhere ( Johnson et al. 2012 , Mizushima et al. 2011 . Cytosolic cargo
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Atg12-Atg5-Atg16L Macroautophagic degradation. An illustration depicting the three steps of autophagosome (AP) formation, nucleation, expansion and maturation. The formation of the AP relies on the concerted effort of the core machinery. The phosphorylation status of the Ulk1 complex attracts different ATG proteins to the formation of the IM. The Beclin1-Atg14L-Vps34 complex enriches the IM and surrounding membrane with PI3P which attracts effector proteins such as WIPI-1 and -2. DFCP1 also cycles from the Golgi to the PI3P-rich IM. As the membrane elongates around the cargo, the tetrameric Atg12-Atg5-Atg16L complex promotes the lipidation of LC3 on PE of the AP growing membrane. Upon completion of the AP, only LC3 remains. During maturation, the AP fuses into the endolysosomal system to form amphisomes and autolysosomes, upon which the contents and inner AP membrane is degraded. Abbreviation: MVB, multivesicular bodies.
ATG proteins contribute toward each of these steps, and overall they can be categorized into six subgroups: the Ulk1 protein kinase complex, the Beclin1-Atg14L-Vps34 lipid kinase complex, the PI3P (phosphatidylinositol-3-monophosphate) binding proteins, Atg9, and the two ubiquitin-like conjugation systems ( Table 1) . The induction of macroautophagy is regulated through the phosphorylation status of the Ulk1 complex, which drives nucleation of the isolation membrane (IM) (or phagophore). Next, the Beclin1-Atg14L-Vps34 kinase enriches the site with PI3P to recruit the PI3P binding proteins such as WIPI-1 and -2 a DFCP1. At present, the site at which the IM is formed is heavily debated (Axe et al. 2008 , Dunn 1990 , Ge et al. 2013 , Hailey et al. 2010 , Hamasaki et al. 2013 , HayashiNishino et al. 2009 , Ylä-Anttila et al. 2009 ; it is still conceivable, however, that the membrane origin may differ depending on the type of macroautophagy that is induced or the cell type that is being interrogated.
After the IM forms, the membrane expands and envelopes the cargo. This process requires the final three subgroups: Atg9 and the two ubiquitin-like conjugation systems (Mizushima et al. 2011) . How Atg9 promotes elongation is unclear, but as a membrane-spanning protein that shuttles across different vesicles, its significance points toward different membrane sources contributing toward AP membrane expansion. The two ubiquitin-like conjugation systems elongate the growing AP membrane by ultimately driving a key reaction: the lipidation of Atg8 and its homologs to the lipid PE (phosphatidylethanolamine) within the growing AP membrane. This result is achieved by two distinct reactions: The first creates an E3-like ligase known as the Atg12-Atg5-Atg16L complex, and the second converts cytosolic Atg8 to its lipidated form (Nishimura et al. 2013) . As the membrane closes to form the AP, the Atg12-Atg5-Atg16L leaves the outer membrane, leaving behind an AP membrane labeled with Atg8. The reported presence of Atg16L on vesicles originating from the plasma membrane suggests another membrane source for elongation, but how Atg16L associates with the membrane is uncertain (Ravikumar et al. 2010) . Moreover, the lipidation of Atg8 may occur only on membranes from the endoplasmic reticulum (ER)-Golgi intermediate compartment (Ge et al. 2013) . It is unclear, however, how these different membrane sources are interrelated if at all. The Atg8 homolog LC3 (microtubule associated protein 1 light chain 3) is the only protein marker of the AP. Mammalian cells have multiple Atg8 homologs, all of which can potentially label the AP by lipidation, and they are divided into two families. The LC3 family has three isoforms, A, B and C, of which LC3B was the first identified (Kabeya et al. 2000) and LC3C is present only in humans. The GR [GABA(A) receptor associated proteins] family has three members, which include GR, GRL1/GEC1 (GABARAP-like protein 1), and GRL2/GATE-16. Amino acid alignments to yeast Atg8 reveal that it is more similar to GRs than to LC3. Indeed, GRL1 is also present in APs (Chakrama et al. 2010) . LC3B, LC3C, and all GR proteins are also highly expressed in the brain. Nonetheless why a large number of mammalian homologs exist is unknown. Weidberg et al. (2010) proposed a functional distinction between the LC3 and GR families in AP formation, but the rationale for this added level of complexity is unclear. As an aside, GR proteins, as their name implies, were initially identified to interact with GABA(A) receptors and to regulate their trafficking in neurons (Leil et al. 2004 , Wang et al. 1999 . Whether these observations are indicative of a dichotomous function of GR or whether there is a yet-unexplored intersection between neuronal macroautophagy and cell surface protein availability needs to be resolved.
The AP next delivers its cargo to the lysosome, and degradation of the substrates as well as the inner AP membrane ensues. Studies indicate that mammalian APs fuse into the endolysosomal system to become first an amphisome and then an autolysosome [collectively known as autophagic vacuoles (AVs)]. Amphisome formation depends on proteins implicated in the biogenesis of MVBs, a specialized late endosome that sorts endocytic proteins for lysosomal degradation (Rusten et al. 2008) . Mutations in ESCRT proteins such as Chmp2b and the AAA+ protein p92/VCP, which are associated with frontotemporal dementias (Lee & Gao 2008 , Watts et al. 2004 , are characterized by defects in macroautophagic degradation (reviewed in Yamamoto & Simonsen 2011) . The dependence on MVBs has promoted the hypothesis that amphisome formation may increase the efficiency of lysosome-mediated degradation. For neurons, amphisome formation may be especially valid because APs must travel long distances before degradation can occur (Hollenbeck 1993 , Larsen et al. 2002 , Maday et al. 2012 .
The fusion of AP membranes raises a vexing question that persists in the field: How are membrane closure and fusion achieved? As have many membrane trafficking events, numerous studies implicate SNARE proteins for both homotypic membrane fusion of the growing AP (Moreau et al. 2011 , Nair et al. 2011 ) and heterotypic membrane fusion to the lysosome (Hamasaki et al. 2013 , Itakura et al. 2012 , Pryor et al. 2004 , Takáts et al. 2013 . If SNAREs are involved, how are they incorporated by the IM or outer AP membrane? Early freeze fracture electron microscopy indicates that the outer AP membrane is smooth and devoid of transmembrane proteins (Fengsrud et al. 2000 , Punnonen et al. 1989 , an observation that may not support the presence of SNAREs.
Selective Autophagy
Although macroautophagy can lead to bulk degradation of substrates in response to starvation, adaptor proteins known as autophagic receptors and selectivity adaptors can promote selective degradation. Adaptor proteins identified thus far include p62/SQSTM1 (Sequestesome 1), NBR1, Nix, NDP52, Alfy/WDFY3, and OPTN (Optineurin) (reviewed in Mijaljica et al. 2011 ). These adaptors have been implicated in the selective elimination of ubiquitinated and nonubiquitinated proteins, various organelles such as mitochondria, and invading pathogens.
Selective autophagy in mammals may be related to a pathway in yeast known as Cvt (cytoplasm to vacuole targeting) (Umekawa & Klionsky 2012) , which depends on the core AP building machinery, as well as specific adaptor proteins. The Cvt adaptor proteins, Atg11 and Atg19, are required to import vacuolar hydrolases such as aminopeptidase I (ApeI) to the vacuole. ApeI oligomerizes into a large aggregate, which is then recognized sequentially by Atg11 and Atg19 to recruit the AP machinery. Although the building machinery is shared for all forms of macroautophagy, ultrastructural studies reveal that the resulting APs are distinct; for bulk degradation, APs fill with cytoplasm and cytosolic material, whereas for Cvt, APs are filled with only aggregated ApeI (Baba et al. 1997) . The tight apposition of the membrane to the cargo is attributed to the direct interaction of Atg11 with Atg8. In mammalian systems, the autophagic receptors directly interact with the Atg8 homologs through an LIR or LRS (LC3 interacting region or recognition www.annualreviews.org • Neural Autophagysequence) (Birgisdottir et al. 2013) . These sequences can differentiate between the LC3 and GR family members, suggesting that the different Atg8 homologs may confer added specificity.
As in Cvt, the priming step in selective autophagy in mammals may be the aggregation of cargo. Whereas the p62-LC3 interaction is the focus of much of its function, p62's alternative name, SQSTM1, aptly describes the ability of p62 to form inclusions by multimerizing through its PB1 domain. Indeed, p62 sequesters ubiquitinated proteins as well as mitochondria (Komatsu et al. 2007a , Narendra et al. 2010 , Nezis et al. 2008 ). This general function of p62 may explain why it is the most pleiotrophic autophagic receptor. As illustrated by aggrephagy and mitophagy, substrate specificity may be acquired through p62's cooperation with other adaptor proteins.
Aggrephagy: The selective degradation of aggregates. The accumulation of ubiquitinated proteins is a hallmark of adult-onset neurodegenerative diseases, and researchers have proposed a role for macroautophagy to intervene in disease progression or prevention (Yamamoto & Simonsen 2011) . Aggrephagy relies on the autophagy receptors, p62, NBR1 (Filimonenko et al. 2010 , Kirkin et al. 2009 ), and Alfy (Autophagy linked FYVE protein), the only identified selectivity adaptor (Clausen et al. 2010 , Filimonenko et al. 2010 . Alfy is a highly conserved member of the BEACH [Beige and Chediak-Higashi syndrome (CHS)] domain proteins, and it mediates the interaction of the p62-and NBR1-positive proteins to Atg12-Atg5 and PI3P (Isakson et al. 2012) . Beyond its role in aggrephagy, little else is known about Alfy function in vivo; however, studies in Drosophila melanogaster reveal that its homolog Blue Cheese (Bchs) is essential for maintaining a healthy adult brain (Finley et al. 2003) , possibly by promoting proper axonal transport of endolysosomal vesicles (Lim & Kraut 2009 ). More recently, OPTN has been implicated in aggregate turnover as well (Korac et al. 2013) .
Although studies in the brain indicate that preformed intraneuronal inclusions can be degraded, whether this process is driven by aggrephagy remains uncertain (Yamamoto & Simonsen 2011) . Alfy is most highly expressed in the brain (Isakson et al. 2012) , and its overexpression can promote the elimination of aggregates in primary cortical neurons (Filimonenko et al. 2010) . Moreover, a recent study using cortico-striatal slice cultures revealed that protein aggregates can be cleared in a macroautophagy-dependent manner and that aggregating proteins are preferentially degraded over bulk cytoplasm (Proenca et al. 2013) . Together these studies strongly suggest that aggrephagy can occur in the brain, but long-term examination in vivo is still required.
Mitophagy: The selective degradation of mitochondria. Similar to aggrephagy, mitophagy relies on the sequestration then targeted degradation of mitochondria (de Vries & Przedborski 2013 , Narendra et al. 2012 . One means by which this may be achieved is through the interplay between a mitochondrial kinase PINK1 (P10 inducible kinase 1) and an E3 ubiquitin ligase Parkin (Narendra et al. 2012) . When mitochondria become damaged, PINK1 stabilizes in the outer mitochondrial membrane, which recruits then phosphorylates proteins, possibly including cytosolic Parkin. Subsequently, Parkin ubiquitinates different outer mitochondrial membrane proteins such as Miro, which in turn attracts the autophagic receptors p62 and Nix (Ding et al. 2010 , Novak et al. 2010 , Schweers et al. 2007 .
As with aggrephagy, the role of mitophagy in the brain is unclear. Mutations in PINK1 and Parkin cause familial Parkinson's disease (fPD), and disease-causing mutations can lead to defects in mitophagy (Geisler et al. 2010) . Nonetheless, mitochondrial abnormalities or dopamine (DA)-related deficits have not been reported in mice deficient for p62, PINK1, or Parkin (Kitada et al. 2007 , Komatsu et al. 2007a , Perez & Palmiter 2005 , Wooten et al. 2008 . In contrast, mice deficient for members of the AP machinery accumulate abnormal mitochondria in the brain (Liang et al. 2010 ). These findings suggest that although mitochondria are eliminated by macroautophagy, bulk macroautophagy is sufficient for mitochondrial turnover in the developing brain. PINK1-Parkin-dependent mitophagy, however, may demonstrate more relevance in aging DA neurons. For example, Dawson and colleagues have found that after a ten-month period, depletion of Parkin in adult substantia nigra leads to neuronal loss (Shin et al. 2011) . Nonetheless, it remains to be seen whether the toxicity observed is due to a defect in mitophagy or other Parkin-related functions.
NEURONAL AUTOPHAGY
All forms of autophagy were discovered under conditions of starvation, and the ensuing biochemical studies revealed that at the cellular level, starvation is translated into signaling through the large, serine/threonine kinase mTOR (mammalian target of rapamycin). mTOR is found in two different complexes (reviewed in Efeyan et al. 2012) and in the form of mTORC1 (mTOR complex I) acts as a negative regulator of macroautophagy. How starvation and mTORC1 inhibition can promote CMA and microautophagy is less certain.
Although the autophagic response to mTORC1 inhibition is robust in most organs, the response in the brain has been controversial. Acute starvation in transgenic mice expressing GFP-LC3 (green fluorescent protein-tagged LC3) triggers a rapid increase in GFP-LC3-positive APs in the liver, muscle, and heart but rarely in the brain, despite strong expression in many neuronal subtypes and glia (Mizushima et al. 2004) . Biochemical measures indicating LC3 lipidation are also difficult to detect in neural tissue. In contrast, other studies indicate that intermittent fasting and mTOR inhibition can induce macroautophagy in neurons (Alirezaei et al. 2010 , Proenca et al. 2013 . Moreover, TSC1 (tubular sclerosis complex I) mutations that lead to hyperactive mTOR appear to chronically inactivate autophagy (McMahon et al. 2012) . The same mutations, however, do not mimic the neurodegenerative phenotype of mice that completely lack the AP machinery (Hara et al. 2006 , Liang et al. 2010 , indicating that mTOR-independent autophagic events continue to occur.
This varied response to mTORC1 may reflect the physiology of the vertebrate brain versus peripheral tissues such as the liver. The primary energy source for vertebrates is glucose, and the brain is its highest consumer. To maintain brain activity during periods of starvation, gluconeogenesis drives the breakdown of glycogen, adipose tissue, and proteins. Under conditions of nutrient deprivation, hepatocytes can account for as much as 75% of the ongoing protein degradation (Mortimore et al. 1989 , Seglen & Bohley 1992 , and thus the liver can lose significant mass (>40%) yet the brain loses much less (Goodman et al. 1984 , Wagenmakers et al. 1984 . Thus unlike the liver, from which we have derived most of our knowledge of autophagy, the brain's drive to degrade proteins in response to mTORC1 inhibition may be blunted. Moreover, depending on how neurons interact with the periphery, how they respond to mTORC1 will vary.
Although mTORC1-dependent autophagy in the brain is controversial, it is clear that autophagy can be induced in the developing and adult brain. In neurons, mechanical stress such as axotomy or nerve crush, excitotoxic stress, and drug-induced toxicity can evoke AP accumulation across neuronal subtypes (Yue et al. 2009 ). Activation may be achieved by mTORC1-independent mechanisms relying on AMP kinase, increasing PI3P levels, and changes in intracellular calcium (reviewed in Johnson et al. 2012) . Further mechanistic understanding of how autophagy is induced in the brain will provide a framework for therapeutic interventions but will also help provide much needed tools that will dissect how autophagic events influence neural function and health.
Genetic studies have firmly established that basal macroautophagy is essential for the development of a healthy brain (Hara et al. 2006 , Komatsu et al. 2006 , Liang et al. 2010 ; however, it can also play a deleterious role, promoting neuronal damage and loss. For example, inhibition of macroautophagy during excitotoxic stress can be protective and potentially promote recovery Neural Autophagy: A summary. A schematic representation summarizing the different autophagic events in different regions of the neuron and the three different glial subtypes discussed in this review. Abbreviations: AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AP, autophagosome; CMA, chaperone-mediated autophagy. (Dong et al. 2012 , Koike et al. 2008 , Yue et al. 2002 . This dichotomy suggests that the impact of autophagy can be influenced not only by neuronal subtype, but also by the neuron's age and where within the neuron that macroautophagy is activated. Moreover, the yet unknown contribution of glial autophagy may also be a key factor in how autophagy affects neural health (Figure 3) .
Neuronal Subtype
Neurons are extremely diverse in form and function and can be readily distinguished by morphology, biochemistry, and activity; it thus may be unsurprising that different neuronal subtypes depend on basal macroautophagy in various ways. This is readily revealed when macroautophagy is conditionally disrupted using Nestin-cre: The pattern of protein accumulation, dysfunction, and death varies across neuronal subtypes (Hara et al. 2006 , Komatsu et al. 2006 . For example, Purkinje cells are among the most vulnerable neurons and degenerate within 12 postnatal weeks. In contrast, midbrain DA neurons are largely spared until 9 months of age (Friedman et al. 2012 ).
Although Purkinje cells require macroautophagy, hyperactivation of macroautophagy can also be neurotoxic (Yue et al. 2002) , indicating that neuronal dependence on this pathway is more complex than the initial studies implied.
Not only is the dependence on macroautophagy subtype specific, but its significance can also vary. Mechanical stressors such as axotomy lead to a rapid induction and accumulation of AVs in neuronal axons and soma. Studies in nigrostriatal DA neurons versus RGCs (retinal ganglia cells) of the optic nerve reveal that the induction of macroautophagy in DA neurons is deleterious (Cheng et al. 2011 ), but in RGCs it is beneficial (Rodríguez-Muela et al. 2012 ). This finding would suggest that in the former, AV accumulation promotes axonal fragmentation and swelling, whereas for the latter, macroautophagy clears and recycles the damaged material to promote an environment that permits regrowth. Why these differences occur is unclear. Nonetheless, the subtype-specific responsiveness and reliance on autophagy indicate that augmenting these pathways systemically may be problematic. Understanding the basis of these differences will play an important role in our understanding of neuronal autophagy overall.
Neuronal Compartments
Soma. The size and specialization of neurons permit macroautophagy to occur independently within different regions of the same cell. Moreover, adaptations of the macroautophagic pathways to support specific neural activities have been observed, particularly for synaptic transmission. APs are synthesized in the soma (Bains et al. 2009 , Lee et al. 2010b , Young et al. 2009 ), but the presence of ER in axons and terminals throughout the neuron (Broadwell & Cataldo 1984) suggests that AP formation can occur broadly. This is particularly the case for axons, but for dendrites it remains unknown. Although AP formation may occur in different regions of the cell, the primary location of lysosomes in adult neurons is the soma (Roberts & Gorenstein 1987) ; thus trafficking events will strongly dictate the efficiency of degradation.
Axons. The ability of APs to form distally in axons has been indicated since the earliest studies with axon injury models (Matthews & Raisman 1972) . Further studies revealed that upon sequestration, the APs mature and form amphisomes while being transported retrograde back to the soma in a dynein/dynactin-dependent manner (Hollenbeck 1993 , Maday et al. 2012 . Many of these studies were performed on neurons of the peripheral nervous system; however, recent examinations of CNS-derived neurons reveal similar findings in culture and in the brain (Wong & Holzbaur 2014 , Yang et al. 2013 .
The axonal autophagic cargoes remain to be characterized, but limited evidence suggests that they are presynaptic proteins and membranous structures such as synaptic vesicles (Yang et al. 2013) . Tau protein, which stabilizes axonal microtubules, may also be degraded by autophagy (Wang et al. 2009 . A deficiency in macroautophagy causes Purkinje cell axons to accumulate aberrant membrane organelles, suggesting that axonal macroautophagy may help to balance membrane networks within the axon to prevent axon dystrophy (Komatsu et al. 2007b) . Similarly, macroautophagy may play a key role in axon outgrowth (Ban et al. 2013 , Coupé et al. 2012 .
Although autophagy in axons is required for neuronal function, a profound accumulation of AVs can also be observed in axons of dying or degenerating neurons. Pathological or pharmacological conditions may disrupt maturation directly, but similar observations can be made if retrograde transport is affected (Yang et al. 2013) . A growing number of studies also implicate macroautophagy in axonopathies such as pcd (Purkinje cell death) (Yang et al. 2013) ; however, studies of peripheral axons reveal that macroautophagy is induced not only during degeneration www.annualreviews.org • Neural Autophagybut also during regeneration (Mohseni 2011) , suggesting that the stimulus for macroautophagy may promote distinct functions.
Synapse development and synaptic activity.
A local role for macroautophagy in axons raises questions about its role in the synapse. Studies in D. melanogaster show that macroautophagy may promote neuromuscular junction growth by reducing the levels of Highwire, an E3 ubiquitin ligase (Shen & Ganetzky 2009 ). In rodents, disruption of Atg7 in midbrain DA neurons causes an altered number of synaptic vesicles and aberrantly evoked DA transmission (prior to the onset of degeneration), consistent with a presynaptic function of macroautophagy in axon terminals (Hernandez et al. 2012) . Early evidence also indicates that macroautophagy acts postsynaptically; cultured neurons treated with N-methyl-D-aspartate (NMDA) demonstrate a profound induction of AP formation (Borsello et al. 2003) . A more recent report demonstrates that depolarization and NMDA-based long-term depression stimulate macroautophagic activity in spines and dendrites, accompanied by the enhanced degradation of GluR1, an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor subunit (Shehata et al. 2012) . In summary, although there is still much for investigators to learn, neurons have adapted the flexibility of macroautophagy to suit their complex needs. Further study examining the role of macroautophagy in neurons will shed more light on how its role may be further extended to plastic changes in the adult brain.
GLIAL AUTOPHAGY
Although we know the fate of neurons upon early deletion of core ATG genes, the fate of glial cells remains largely unexamined. Like neurons, glial cells represent a diverse and specialized collection of cell types and thus may also demonstrate temporal-and subtype-dependent reliance on autophagy. Unlike neurons, however, glial cells replicate and respond more robustly to nutrient changes and thus may also demonstrate characteristics similar to peripheral cells. The limited studies available indicate that glia such as astrocytes and oligodendrocytes can mount a macroautophagic response to accumulated proteins in an mTORC1-dependent and -independent manner ( Janen et al. 2010 , Schwarz et al. 2012 , Tang et al. 2008 , Zschocke et al. 2011 ), but the efficaciousness of this response is unclear. Autophagy-induced cell death in microglial cells has also been reported (Arroyo et al. 2013) .
Glial subtypes may also have adapted macroautophagy to promote specialized functions. Oligodendroctyes increase myelination in response to an upregulation of macroautophagy in both a dysmyelination mutant and control animals . The peripheral Schwann cells show a similar responsiveness to macroautophagy (Fortun et al. 2003 , Rangaraju et al. 2010 . Moreover, Schwann cells associated with regenerating axons may upregulate macroautophagy (Mohseni 2011) . These data suggest that glia may reclaim membranes and proteins by macroautophagy to promote myelinating events. Astrocytes may rely on macroautophagy to prune axons (Song et al. 2008) . Thus, in light of the tight interrelationship shared between neurons and glia, the disruption of macroautophagy in glia may have a profound non-cell-autonomous influence on neuronal health and development. How other forms of autophagy impact glial health and function also need to be examined.
AUTOPHAGY AND NEURODEVELOPEMENT
Macroautophagy is highly active during development from early preimplantation onward (Mizushima & Levine 2010) ; generally, however, beyond the postnatal degenerative phenotype that has been reported (Hara et al. 2006 , Komatsu et al. 2006 , Liang et al. 2010 , the loss of ATG proteins in early development does not lead to gross structural changes in the brain (Kuma et al. 2004) . A moderate exception thus far has been hypothalamic neurons; macroautophagy is essential for axonal projections to mature (Coupe et al. 2012) . Hypothalamic neurons project their axons postnatally, which may account for the differential reliance on axonal macroautophagy. Intrinsically different macroautophagic activity is also reflected in a recent study, which shows that macroautophagy maintains postnatal neural stem cells and promotes neurogenesis but that it is dispensable for these purposes during the embryonic period (Wang et al. 2013) .
In contrast, disruption of proteins involved in modulating macroautophagy reveals a more striking impact on neurodevelopment. Ambra1 is a vertebrate protein that acts as a positive regulator of Beclin1 (Fimia et al. 2007 ). During development, it is highly expressed in the neural tube, and its deficiency leads to neural tube closure defects, possibly due to unchecked hyperproliferation of cells at the onset of neurulation. Moreover, several autosomal recessive disorders, Vici syndrome (Cullup et al. 2013) , and two different hereditary spastic paraparesis (Oz-Levi et al. 2012 , Vantaggiato et al. 2013 ) demonstrate motor and cognitive delays, intellectual disability, and callosal agenesis or hypogenesis, which suggests that degradation by macroautophagy is essential for neuronal connectivity and axonal outgrowth. The proteins involved, EPG5, ZFYVE26, and TECPR2, have been implicated in AP maturation (Behrends et al. 2010 , Vantaggiato et al. 2013 , Zhao et al. 2013 . In mice deficient for Epg5, the callosal phenotype was replicated, but other symptoms associated with Vici syndrome were not observed (Zhao et al. 2013) . A deletion of ZFYVE26 or TECPR2 has not yet been reported. Why proteins involved in AP maturation, rather than the core ATG proteins, are more essential to CNS development is unclear. Unlike ATG proteins, these proteins may help to balance autophagic versus endocytic degradation; thus the neurodevelopmental defects may reflect a more generalized disruption of vesicle trafficking.
AUTOPHAGY, AGING, AND NEURODEGENERATION
Studies of postmortem brains of AD (Alzheimer's disease), PD (Parkinson's disease), and HD (Huntington's disease) gave some of the earliest evidence that macroautophagy may contribute to neurodegeneration. Recent studies have shown that macroautophagy plays an important role in ALS (amyotrophic lateral sclerosis). Moreover, the dysregulation of CMA has been implicated in the pathogenesis of adult-onset disorders, particularly PD (Koga & Cuervo 2011) . Efforts to decipher how autophagy impacts neurodegeneration has highlighted the complex role that autophagy plays in the brain.
Alzheimer's Disease
Although the classic pathological hallmarks of AD include intraneuronal neurofibrillary tangles and the extracellular senile plaques, another prominent feature is the presence of "autophagic neurites," dystrophic neurites characterized by swollen axonal or dendritic varicosities filled with AVs (Nixon et al. 2005) . Although the pathogenic significance of these structures remains elusive, several reports suggest that upregulated protein synthesis or transcription of lysosomal components and cellular factors promoting autophagy is upregulated in AD brains (Ginsberg et al. 2010 , Lipinski et al. 2010 , Nixon & Cataldo 2006 . Although this upregulation may be an attempt by the neurons to clear amyloid precursor protein (APP) products such as Abeta and CTF (C-terminal fragment) (Steele et al. 2013b , Vingtdeux et al. 2011 , the accumulation of AVs indicates that AV maturation fails (Nixon & Cataldo 2006) . The lack of degradation and completion of the autophagic process promotes a state of autophagic stress (Chu 2006) , which contributes towards pathogenesis. Other studies in postmortem AD brains, however, show that mTORC1 is hyperactivated (Li et al. 2005) and Beclin 1 protein levels are decreased (Pickford et al. 2008) , indicating that autophagic activation may be compromised in AD brains. As mentioned above, these apparently contradictory findings may be influenced largely by from where and when the samples were collected. Nonetheless, the aberrant accumulation of AV structures in postmortem samples is indicative that at the end stage of disease, degradation by macroautophagy is failing. When and how macroautophagy begins to exert toxicity are still uncertain.
In early-onset FAD (familial AD), defects in macroautophagy may be an underlying cause. The most common cause of FAD is mutations in PS1 (Presenilin 1), a multispanning intramembrane protease best known as a member of γ-secretase, a multimeric enzyme complex responsible for the cleavage of several substrates including APP and Notch (De Strooper et al. 2012) . A growing number of studies indicate that PS1 also has functions outside γ-secretase (De Strooper et al. 2012) , such as lysosomal degradation and AP maturation (Lee et al. 2010b , Neely et al. 2011 ). PS1 mutations have been implicated in disruption of endolysosomal transport and function (Lee et al. 2010a) , which are essential for AP maturation and degradation. The exact mechanism, however, remains to be clarified (Zhang et al. 2012 ).
Parkinson's Disease
Genetic and experimental evidence strongly implicates a role for both macroautophagy and CMA in PD. PD is characterized by the degeneration of DA neurons in the nigrostriatal pathway and the presence of Lewy bodies, an eosinophilic cytoplasmic inclusion comprised largely of α-syn (α-synuclein) fibrils, and Lewy neurites, similar proteinaceous structures composed of abnormal α-syn fibrils and granular material. Beyond the recessive PINK1 and Parkin mutations that diminish mitophagy (see Mitophagy, above), aberrant levels or activity of autosomal dominant mutations in α-syn and LRRK2 may compromise basal macroautophagy and CMA, likely underlying the pathogenesis of PD.
α-Syn is linked to familial as well as sporadic PD and may either modulate or be a target for macroautophagy. Although the physiologic function of α-syn is unclear, the available evidence suggests that it is involved in vesicle trafficking (Cooper et al. 2006 , Nemani et al. 2010 . Along these lines, excessive α-syn may impair macroautophagy by inhibiting the small GTPase Rab1a and altering the localization of Atg9 (Winslow et al. 2010) . α-syn fibrils also reduce AP turnover (Tanik et al. 2013) . In contrast, aggregates containing disease-causing mutations in α-syn can be cleared by an upregulation of macroautophagy (Sarkar et al. 2007 , Steele et al. 2013a , and clearance can be dependent on aggrephagy (Filimonenko et al. 2010) .
Genetic mutations in LRRK2 are linked to the most common familial forms of PD, and several studies find that LRRK2 participates in the regulation of macroautophagy (reviewed in Gómez-Suaga et al. 2012) . Although the molecular mechanism is not well understood, the pharmacological inhibition of LRRK2 kinase activity promotes macroautophagy. Nonetheless, despite the autophagy-associated defects in LRRK2 animal models, these deficiencies may be several steps downstream from LRRK2. Whether members of the AP machinery are a direct target remains to be seen.
Both wildtype α-syn and LRRK2 proteins are CMA substrates, and their PD-linked mutations impair CMA-mediated degradation (Cuervo et al. 2004 , Orenstein et al. 2013 . Moreover, the interaction between α-syn and oxidized DA also interferes with CMA activity, broadening the impact of dysfunctional CMA to idiopathic PD (Martinez-Vicente et al. 2008) . The mechanisms of CMA inhibition differ between the two proteins: monomeric α-syn blocks internalization, whereas LRRK2 evokes a more complex self-perpetuating inhibitory effect (Orenstein et al. 2013) . In light of the cross talk between CMA and macroautophagy, it would be interesting to determine if a corresponding upregulation of macroautophagy occurs in neurons with compromised CMA. Future in vivo studies are anticipated.
Huntington's Disease
Currently, one of the primary therapeutic questions in HD is how to preferentially eliminate the disease-causing protein (Sah & Aronin 2011) , and one approach investigators are exploring is the activation of macroautophagy. Unlike other adult-onset neurodegenerative disorders, all known cases of this hereditary disorder are caused by a trinucleotide repeat expansion in the gene HD. Elimination of the resulting mutant protein product in experimental models not only halts the progression of pathogenesis, but also promotes amelioration of the disease (Kordasiewicz et al. 2012 , Régulier et al. 2003 .
Whether the activation of macroautophagy in the HD brain will be beneficial, however, still remains uncertain. The inhibition of mTORC1 in vivo showed early promise (Ravikumar et al. 2004) , but the complexity of mTORC1 inhibition and neural autophagy suggests alternative therapeutic approaches may be necessary (Fox et al. 2010 , King et al. 2008 , Tsvetkov et al. 2010 . Despite the numerous studies examining macroautophagy and HD, a fundamental question remains: Can the full-length mutant htt protein be eliminated by macroautophagy? Htt is a 350-kDa protein; the pathogenic mutation is present at the very N-terminus. Early studies indicated that transgenic expression of a short N-terminus fragment was sufficient to recapitulate key aspects of HD (Mangiarini et al. 1996) , and these fragments have been studied primarily in the context of autophagy. Although subsequent biochemical studies suggest that this fragment is pathogenically relevant (Landles et al. 2010) , questions remain whether the fragment alone truly represents HD (Bowles et al. 2012) .
Although a role for autophagic stress has not been demonstrated in HD, some studies have reported a potential dysfunction in basal macroautophagy (Heng et al. 2010 , Martinez-Vicente et al. 2010 . In a curious twist, complete deletion of the polyglutamine stretch, even nonpathogenic lengths, leads to enhanced neuronal macroautophagy . These data imply that Htt, and specifically its polyglutamine stretch, can modulate this pathway. The regulation may likely be due to Htt's role in retrograde transport, which can be impeded in a polyglutamine-lengthdependent manner (Colin et al. 2008 , Liot et al. 2013 , Wong & Holzbaur 2014 . Phosphorylation of Htt can overcome the polyglutamine-dependent inhibition, thus providing an added avenue by which macroautophagy deficiencies may be overcome.
Amyotrophic Lateral Sclerosis
An emerging hypothesis for ALS pathogenesis is defective protein degradation, and of particular interest is the functional convergence on macroautophagy (Robberecht & Philips 2013 , Thomas et al. 2013 . ALS is a degenerative disease that affects motor neurons in the motor cortex, the brain stem, and the spinal cord. Although research has not identified a mutation in core ATG genes, two selective macroautophagy proteins, p62/SQSTM1 (Hirano et al. 2013 , Shimizu et al. 2013 and OPTN (Maruyama et al. 2010) , have recently been linked to sporadic and familial ALS, suggesting defects in aggrephagy. Both proteins can be found in ALS-associated inclusions (Mizuno et al. 2006 , Osawa et al. 2011 , but why motor neurons may rely on aggrephagy still needs to be established.
Upregulation of macroautophagy has been both promising (Castillo et al. 2013 , Feng et al. 2008 and disappointing for ALS (Gill et al. 2009 , Pizzasegola et al. 2009 , Zhang et al. 2011 . In all of these studies, ALS was modeled using transgenic overexpression of mutant SOD1 (superoxide dismutase-1). These models show a profound accumulation of AVs in motor neurons (Li et al. 2008 , Tian et al. 2011 , and thus the strength of the induction may have profoundly influenced the outcome. Whether SOD1-dependent ALS and the rare OPTN-and p62-dependent forms of ALS converge remains to be determined. But if there is convergence, upregulation of basal macroautophagy may not suffice if substrates cannot be properly targeted for degradation.
CONCLUSION
Understanding the role of autophagy in neurodegeneration reignited our interest in neural autophagy, and over the past decade, the complexity of these essential pathways was revealed. Although many outstanding questions still remain, it is incontrovertible that autophagy plays a vital role in neurons and glia, far beyond their role of eliminating nonessential proteins. As scientists continue to delve deeper into the regulation and import of autophagy, we will gain further insight into how these specialized cells use autophagic pathways, ultimately helping to determine how modulation of these pathways influences neural development and contributes toward neural disease.
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